NEW YORK, June 15, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy (PDT) technology platform for the prevention and treatment of dermatological skin conditions, announced that Richard Christopher, Vice President, Finance and Chief Financial Officer, will present a corporate overview at the Inaugural Marcum MicroCap Conference on June 20th at the Roosevelt Hotel in New York City. Mr. Christopher is scheduled to present at 11:30am ET.
